Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 61.87B | 61.13B | 61.49B | 59.14B | 57.08B | 51.78B |
Gross Profit | 12.66B | 12.43B | 11.97B | 10.76B | 10.32B | 9.34B |
EBITDA | 6.20B | 7.63B | 7.18B | 5.32B | 4.81B | 3.99B |
Net Income | 3.42B | 3.30B | 3.17B | 2.47B | 2.18B | 1.60B |
Balance Sheet | ||||||
Total Assets | 62.61B | 64.55B | 64.71B | 57.77B | 56.02B | 54.06B |
Cash, Cash Equivalents and Short-Term Investments | 11.09B | 12.19B | 12.44B | 16.37B | 16.18B | 16.95B |
Total Debt | 6.63B | 5.87B | 7.00B | 6.84B | 6.34B | 6.37B |
Total Liabilities | 22.43B | 23.38B | 24.26B | 22.66B | 22.51B | 23.33B |
Stockholders Equity | 38.14B | 39.21B | 38.67B | 33.45B | 31.97B | 29.42B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 4.16B | 4.96B | 3.57B | 1.28B | 2.75B |
Operating Cash Flow | 0.00 | 4.84B | 5.54B | 4.49B | 2.03B | 3.25B |
Investing Cash Flow | 0.00 | -1.04B | -219.00M | -1.17B | -613.00M | -409.00M |
Financing Cash Flow | 0.00 | -4.68B | -2.83B | -2.53B | -1.58B | -928.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥8.56B | 11.47 | 2.50% | 2.20% | -6.32% | ||
80 Outperform | ¥12.26B | 13.36 | 2.27% | 14.84% | 7.57% | ||
80 Outperform | ¥37.10B | 10.17 | 3.81% | -0.59% | 6.83% | ||
71 Outperform | ¥26.18B | 16.33 | 3.04% | 5.01% | -5.30% | ||
71 Outperform | ¥12.34B | 13.46 | 1.85% | 3.54% | 6.14% | ||
66 Neutral | ¥4.90B | 5.41 | 2.43% | 0.09% | 100.67% | ||
65 Neutral | $10.69B | 15.75 | 5.51% | 1.90% | 2.72% | -26.43% |